Summary.-Collagen-peptidase activity in extracts of HeLa cells and human tumours is inactivated by Razoxane (ICRF-159), cyclophosphamide, 5-fluorouracil, thiotepa, aprotinin, EDTA and phenanthroline. As this activity, in association with other enzymes, may contribute to tissue lysis in cancers, chemical intervention may reduce invasiveness and modify the processes of infiltration and metastasis. Accordingly, some drugs used in therapy or for the prevention of metastasis may produce their observed effects by a combination of factors including enzyme inhibition.
FOLLOWING study of collagenase enzymes with synthetic peptides by Nagai et al. (1960) , introduction of the chromophore substrate p-phenyl-azo-benzyloxycarbonyl-pro-leu-gly-pro-D.arginine by Wunsch and Heidrich (1963) enabled collagen-peptidase activity, specific for apolar peptide sequences analogous to those of the collagen molecule, to be identified and assayed in mouse and chick embryo and in human HeLa cells by Strauch (1967) , Strauch and Vencelj (1967) and Strauch et al. (1968) . Although assays of tumour peptidase with Pz-substrate by Keiditsch and Strauch (1970) corresponded closely with results obtained by the method of Nagai et al. (1966) using 14C-labelled collagen as substrate, collagen peptidase and collagenase when isolated and purified are not identical. A similar distribution of the enzymes suggesting a close functional relationship was also recorded by Robertson and Williams (1969) in an invasive rat epithelioma where collagen-peptidase and true collagenolytic activity were found in corresponding regions of the tumour periphery.
Langer et al. (1968) and Strauch (1968, 1970) found high levels of collagen peptidase in human tumours, and in 1972 Strauch showed benign and noninvasive tumours to be moderately increased, and malignant tumours of both epithelial and mesenchymal origin to be much increased compared with tumourfree tissue. Invading margins of malignant tumours had high activity, with lower values in the centre, still higher than surrounding normal tissues. Other workers have identified neutral collagenase activity in tumours, corresponding to that described by MeCroskery et al. (1975) .
Although collagen-and reticulin-containing structures are among the most persistent of mammalian tissues, growth of cancers frequently accompanies extensive breakdown of adjacent connective tissue, which takes the form of swelling followed by disorganization and dissolution (Birbeck and Wheatley, 1965; Hamperl, 1967; Frithiof, 1972) . Such tissue destruction, associated with elevated levels of hydrolytic enzymes from neoplastic and host cells of the cancer and its stroma, is believed to contribute to infiltration, invasiveness and possibly metastasization (Pearse et al., 1961; Sylven, 1961; Cameron, 1966; Latner et al., 1974; Carter, 1976; Easty and Easty, 1976 (Strauch, 1972) suggested that inhibition of the responsible enzymes might control and possibly reduce neoplastic infiltration (Rassegna, 1971; Strauch, 1972) . Protease inhibitors restore contact inhibition (Goetz et al., 1972) and reduce malignant invasion. Latner et al. (1974) using the protease inhibitor Trasylol (aprotinin) observed reduced invasiveness and tumour size. Boggust (1976) (Seifter and Gallop, 1962; Werb et al., 1974; Boggust, 1976 For enzyme activity, cells were extracted 30 min at 37°C with veronal-acetate buffer pH 7-2 (Documenta Geigy, 1962) diluted to 1-6 vols with water (1 ml to 106 cells) and centrifuged 10 min at 35,000 g. The pellet was twice dispersed and re-extracted at 37°C, the combined supernatant being stored at -25°C before standardization with p-phenyl-azobenzyl -oxycarbonyl -pro -leu -gly -pro -Darginine.
Tumours from surgery, examined histologically, included adenocarcinomas of colon, rectum and kidney, squamous carcinomas of vulva, scirrhous carcinomas of breast, invasive squamous carcinoma ot ear and differentiated squamous carcinoma of finger. Tumour (0 5 g), free from normal tissue, fat, necrotic or infected mnaterial, was disintegrated by 4 passes at -25°C in the Biotec X-press, (lispersed in diluted veronal-acetate buffer, pH 7-2 (1 ml) and centrifuged for 10 min at 5°C and 30,000 g. The residue was suspended x 4 and re-extracted in 0 5 ml portions of cold buffer, the combined supernatants being stored at -25°C. Only a limited number of assays could be performed with the extract from each tumour.
For assay, mixtures containing serial dilutions of cell or tissue extract, or buffer control (0-25 inl) and buffer (0.5 ml) were preincubated at 37°C for 1 h before adding substrate solution (0 4 mg/ml in buffer) or buffer (0 5 ml) with incubation for 15 min. After adding 0.500 citric acid (2.5 ml) extracts in ethyl acetate (2 x 2-5 ml) combined and dried over anhydrous Na2SO4 gave optical densities at A=320 nm.
For assay of inhibition, mixtures containing cell or tissue extract (0(25 ml) serial dilutions of test substance in buffer prepared with minimal warming or control buffer (0-25 ml) and buffer (0-25 ml) were set up in duplicate and preincubated at 37°C for 1 h; substrate solution in buffer (0.5 ml) was added to one series and buffer (0 5 ml) to the other as controls: all were incubated for 15 min at 37°C and treated as described above. Inhibition of collagen-peptidase was calculated from the dilution/optical-density curve obtained by assay of serially diluted untreated extracts.
RESULTS
Representative findings are presented as Go inhibition of collagen-peptidase activity in HeLa extracts (Table I) and tumour extracts (Table II) Excepting aprotinin, for which no comparison can be expressed in molar units, decreasing inhibition of tumour peptidase was observed in the order phenanthroline, EDTA, Razoxane, cyclophosphamide, thiotepa, 5-FU. With HeLa extracts, EDTA and 5-FU were rather more effective than phenanthroline and thiotepa respectively.
The results show better than 50% inactivation of tumour collagen peptidase at concentrations of inhibitor substantially less than upper levels for therapy cited for Razoxane (ICRF-159) (Wasserman et al. 1973 ) and for cyclophosphamide, aprotinin and EDTA (Martindale, 1972) . 5-FU produced variable levels of inhibition and not all tumour extracts were inhibited. Phenanthroline, a potent inhibitor of collagen peptidase, produces a neuromuscular reaction in mice at levels above 5 ,ug/g (Peters, 1975) .
No inhibition was seen with N-acetylglucosamine, bleomycin, colchicine, cytarabine, dactinomycin, daunorubicin, iodoacetamide, levamisole, methotrexate, phosphocreatine, vinblastine or vincristine.
No overall biochemically acceptable reaction mechanism can be proposed, as the lack of specificity in the inhibitory compounds indicates that the biological situation is complex and may involve more than the blockade of a single enzymesubstrate reaction. As incubation of test substances in buffer showed no significant change of pH, reduced hydrolysis of substrate is not due to enzyme denaturation or to the effect of a less favourable pH upon activity.
DISCUSSION
Certain cytotoxic drugs have been shown to inactivate the collagen peptidase from HeLa cells in culture as well as in extracts of spontaneous human tumours. In addition to malignant cells, tumours may contain non-neoplastic host cells infiltrated into the stroma, including leucocytes, macrophages and fibroblasts. Although such cells have been reported, by various authors, to contain collagenolytic enzymes, no information is available specifically about their collagen-peptidase activity or its inhibition. Accordingly the overall contribution of such drugs to the control of tissue lysis around tumours has yet to be assessed in full.
The role of collagen peptidase in relation to intact macromolecules of tissue structures in the environment of tumours is considered to involve the continuation and extension of lysis begun by the action of true proteases with which they are closely associated.
The relevance of collagen-protease and collagen-peptidase activity to invasiveness and metastasization is related to the weakening of, or creation of defects in, physical barriers to tumour growth. Natural substrates include components and degraded forms of glycoprotein or mucopolysaccharide such as are found in collagen, reticulin, fibrin and the ground substance in matrix of basement membrane, connective tissue, intercellular cement, or in the perithelial structure of the micro-vascular system round the tumour. Lysis of these materials may release cells from the tumour mass, open up pathways for invasion into surrounding areas, or allow passage of cancer cells into the lumen of adjacent lymphatic or blood capillaries for transport to metastatic sites.
Inhibitors of collagenase and collagenpeptidase activity modify the environment of cancers by reducing the hydrolysis of substances which prevent tumour-cell release and movement. By constraining the tumour within the surrounding stroma, blockade of expansive and invasive growth may produce a state like basal-cell carcinomas, which form an enveloping capsule usually staining for reticulin. Such tumours are potentially invasive but, if unable to lyse their capsule, remain benign and undergo maturation and keratinization. By reducing lysis of reticulin-like components in capillary perithelium, enzyme inhibition may con-tribute to vascular integrity, reduce the incidence of haemorrhage round tumours, and reduce the number of malignant cells penetrating the circulatory system, as reported for ICRF-159 in a metastasizing mouse tumour by Salsbury et al. (1970) . A synergistic combination of the enzymeinhibitors ICRF-159 and o-phenanthroline markedly protected tumour-bearing mice from metastasization (Boggust, 1976) .
Taken in conjunction with the cytostatic and cytotoxic effect of these drugs on the proliferating cells of the tumour and its stroma, it is possible that observed remissions in tumour viability may be due to the interaction of several factors including those outlined above. 
